...
首页> 外文期刊>Journal of Surgical Oncology >Management of carcinoma of the gallbladder: a single-institution experience in 16 years.
【24h】

Management of carcinoma of the gallbladder: a single-institution experience in 16 years.

机译:胆囊癌的治疗:16年的单一机构经验。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Radical surgery is the only curative treatment for carcinoma of gallbladder. This study aimed to evaluate the outcome of patients with carcinoma of gallbladder managed in a single institution over 16 years. METHODS: From April 1988 to November 2003, 86 patients (29 males, 57 females) were diagnosed to have carcinoma of gallbladder. Tumor staging, treatment modalities and clinical outcome of these patients were evaluated. Thirty-two patients (37%) had early stage (TNM stage I or II) disease whereas 54 patients (63%) had advanced stage (TNM stage III or IV) disease. Curative treatment by surgical resection was performed in 23 patients (27%). RESULTS: Overall survival was significantly better in patients with curative treatment (1-year: 85%; 2-year: 63%; 3-year: 55%) than those with palliative treatment (1-year: 11%; 2-year: 3%; 3-year: 0%; P < 0.01). Using Cox regression model, curative treatment was the only independent prognostic factor affecting overall survival of patients with carcinoma of gallbladder. A significantly better survival was associated with curative treatment compared with palliative treatment in patients with incidental gallbladder cancer. The median survival was 33.9 months for the curative treatment group versus 3 months for the palliative treatment group (P = 0.0001). CONCLUSION: Favorable survival outcome can be achieved in patients with carcinoma of gallbladder after curative resection.
机译:背景:根治性手术是唯一治疗胆囊癌的方法。这项研究旨在评估在单一机构中管理了16年的胆囊癌患者的预后。方法:从1988年4月至2003年11月,共诊断出86例胆囊癌(男29例,女57例)。对这些患者的肿瘤分期,治疗方式和临床结果进行了评估。三十二名患者(37%)患有早期(TNM I或II期)疾病,而54名患者(63%)患有晚期(TNM III或IV期)疾病。 23例(27%)通过手术切除进行了治疗。结果:治愈性患者(1年:85%; 2年:63%; 3年:55%)的总生存期明显优于姑息治疗(1年:11%; 2年) :3%; 3年:0%; P <0.01)。使用Cox回归模型,治愈性治疗是影响胆囊癌患者总体生存的唯一独立预后因素。与偶发性胆囊癌患者相比,姑息治疗与治愈性治疗相关的生存率显着提高。治愈性治疗组的中位生存期为33.9个月,而姑息治疗组为3个月(P = 0.0001)。结论:胆囊癌根治性切除术后患者生存期良好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号